Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.